BUDDI AI Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
238
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
BUDDI AI General Information
Description
Developer of a healthcare artificial intelligence platform intended to improve care and reimbursement outcomes. The company's platform combines features that assist in automating functions such as medical coding and billing, denials predictions, and clinical document improvement, enabling the healthcare industry to streamline clinical and revenue cycle functions.
Contact Information
Website
www.buddi.aiCorporate Office
- 311 West 43rd Street
- 14th Floor
- New York, NY 10036
- United States
Corporate Office
- 311 West 43rd Street
- 14th Floor
- New York, NY 10036
- United States
BUDDI AI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Apr-2021 | $100K | Completed | Generating Revenue | ||
| 1. Later Stage VC | 01-May-2019 | $100K | $100K | Completed | Generating Revenue |
BUDDI AI Comparisons
Industry
Financing
Details
BUDDI AI Competitors (4)
One of BUDDI AI’s 4 competitors is Nym (Enterprise Systems), a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nym (Enterprise Systems) | Venture Capital-Backed | New York, NY | ||||
| Curai Health | Venture Capital-Backed | San Francisco, CA | ||||
| nference | Venture Capital-Backed | Cambridge, MA | ||||
| Optum | Private Equity-Backed | Eden Prairie, MN |
BUDDI AI Patents
BUDDI AI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4451281-A1 | System and method for anonymizing medical records | Inactive | 18-Apr-2023 | ||
| EP-4246265-A1 | System and method for predictive analytics for fitness of test plan | Inactive | 16-Mar-2022 | ||
| US-20230297091-A1 | System and method for predictive analytics for fitness of test plan | Inactive | 16-Mar-2022 | ||
| EP-4246264-A1 | Analytical system for surface mount technology (smt) and method thereof | Inactive | 15-Mar-2022 | ||
| US-20230297098-A1 | Analytical system for surface mount technology (smt) and method thereof | Inactive | 15-Mar-2022 | G05B23/0283 |
BUDDI AI Signals
BUDDI AI Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DEIA Catalyst | Accelerator/Incubator | |||
| HITLAB Innovators | Accelerator/Incubator | |||
| Plug and Play | Accelerator/Incubator | |||
| BlueHill Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority |
BUDDI AI FAQs
-
When was BUDDI AI founded?
BUDDI AI was founded in 2013.
-
Where is BUDDI AI headquartered?
BUDDI AI is headquartered in New York, NY.
-
What is the size of BUDDI AI?
BUDDI AI has 238 total employees.
-
What industry is BUDDI AI in?
BUDDI AI’s primary industry is Enterprise Systems (Healthcare).
-
Is BUDDI AI a private or public company?
BUDDI AI is a Private company.
-
What is BUDDI AI’s current revenue?
The current revenue for BUDDI AI is .
-
How much funding has BUDDI AI raised over time?
BUDDI AI has raised $100K.
-
Who are BUDDI AI’s investors?
DEIA Catalyst, HITLAB Innovators, Plug and Play, BlueHill Capital, and are 5 of 10 investors who have invested in BUDDI AI.
-
Who are BUDDI AI’s competitors?
Nym (Enterprise Systems), Curai Health, nference, and Optum are competitors of BUDDI AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process